Guizhou Xinbang Pharmaceutical Co., Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) is 3.50

According to Guizhou Xinbang Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.50. This represents a change of 2.16% compared to the average of 3.43 of the last 4 quarters.

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) Historical Current Ratio (quarterly & annually)

How has 002390.SZ Current Ratio performed in the past?

The mean historical Current Ratio of Guizhou Xinbang Pharmaceutical Co., Ltd. over the last ten years is 1.95. The current 3.50 Current Ratio has changed 17.86% with respect to the historical average. Over the past ten years (40 quarters), 002390.SZ's Current Ratio was at its highest in in the September 2025 quarter at 3.57. The Current Ratio was at its lowest in in the March 2019 quarter at 1.21.

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Guizhou Xinbang Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) Average Current Ratio

How has 002390.SZ Current Ratio performed in the past?

The current Current Ratio of Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) Current Ratio vs. Peers

How is 002390.SZ’s Current Ratio compared to its peers?

Guizhou Xinbang Pharmaceutical Co., Ltd.’s Current Ratio is less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (6.22), greater than Shenzhen Salubris Pharmaceuticals Co., Ltd. (2.34), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (2.15), greater than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (2.11), greater than Guizhou Bailing Group Pharmaceutical Co., Ltd. (0.95), greater than Boiron S.A. (2.22), greater than Cann Group Limited (0.42), greater than Emergent Health Corp (0.14), greater than Halo Collective Inc. (1.40), greater than James E. Wagner Cultivation Corporation (1.48),

Build a custom stock screener for Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guizhou Xinbang Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guizhou Xinbang Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.